scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0272-6386(05)80012-5 |
P698 | PubMed publication ID | 11325678 |
P2093 | author name string | M. Maccarrone | |
C. Meloni | |||
C. U. Casciani | |||
A. Finazzi-Agrò | |||
M. Taccone-Gallucci | |||
N. Cococcetta | |||
S. Manca-di-Villahermosa | |||
P2860 | cites work | Involvement of 5-lipoxygenase in programmed cell death of cancer cells | Q82498578 |
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes | Q28289034 | ||
Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein | Q28505058 | ||
Vitamin E as an antioxidant agent | Q33813880 | ||
Vitamin E consumption and the risk of coronary heart disease in men. | Q34363912 | ||
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes | Q40690752 | ||
Leukotriene B4 is involved in hemodialysis-associated neutropenia | Q42480613 | ||
Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade | Q42990984 | ||
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter | Q48418701 | ||
Vitamin E consumption and the risk of coronary disease in women | Q50126258 | ||
Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation | Q69274816 | ||
Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients | Q71306942 | ||
Membrane modifications in human erythroleukemia K562 cells during induction of programmed cell death by transforming growth factor beta 1 or cisplatin | Q71740095 | ||
Vitamin E | Q72414750 | ||
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
Red blood cell membrane oxidative damage and renal impairment in uremic patients under conservative treatment | Q73447276 | ||
Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis | Q73487571 | ||
Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation | Q73932786 | ||
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients | Q74238216 | ||
5-Lipoxygenase gene expression in hemodialysis | Q74277558 | ||
A new alternative for prostate cancer treatment in Spain | Q77797676 | ||
Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis | Q78197793 | ||
P433 | issue | 5 | |
P921 | main subject | hemodialysis patient | Q126109077 |
vitamin | Q34956 | ||
P304 | page(s) | 964–969 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
P1476 | title | Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route | |
P478 | volume | 37 |
Q77147475 | Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation |
Q37416809 | Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis |
Q43144144 | Multiple antioxidants and L-arginine modulate inflammation and dyslipidemia in chronic renal failure rats |
Q46987172 | N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity |
Q38031537 | Oxidative stress in ulcerative colitis: an old concept but a new concern |
Q37728979 | Pro-Resolving Molecules-New Approaches to Treat Sepsis? |
Q36691351 | Vitamin E in renal therapeutic regiments |
Search more.